ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 162 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $396,000 | -38.3% | 40,209 | -32.1% | 0.08% | -56.4% |
Q4 2020 | $642,000 | -11.0% | 59,209 | -15.4% | 0.18% | -29.3% |
Q3 2020 | $721,000 | -30.9% | 70,000 | +40.0% | 0.26% | -37.1% |
Q2 2020 | $1,044,000 | +67.6% | 50,000 | -21.6% | 0.41% | -72.3% |
Q1 2020 | $623,000 | – | 63,750 | – | 1.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |